Correlation Between Neurosense Therapeutics and Better Therapeutics

Can any of the company-specific risk be diversified away by investing in both Neurosense Therapeutics and Better Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurosense Therapeutics and Better Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurosense Therapeutics and Better Therapeutics, you can compare the effects of market volatilities on Neurosense Therapeutics and Better Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurosense Therapeutics with a short position of Better Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurosense Therapeutics and Better Therapeutics.

Diversification Opportunities for Neurosense Therapeutics and Better Therapeutics

0.17

Correlation Coefficient

Neurosense Therapeutics  Better Therapeutics

Average diversification

The 3 months correlation between Neurosense and Better is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Neurosense Therapeutics and Better Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Better Therapeutics and Neurosense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurosense Therapeutics are associated (or correlated) with Better Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Better Therapeutics has no effect on the direction of Neurosense Therapeutics i.e., Neurosense Therapeutics and Better Therapeutics go up and down completely randomly.

Pair Corralation between Neurosense Therapeutics and Better Therapeutics

If you would invest  73.00  in Better Therapeutics on September 17, 2024 and sell it today you would earn a total of  0.00  from holding Better Therapeutics or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	1.54%
Values	Daily Returns

Neurosense Therapeutics  vs.  Better Therapeutics

Neurosense Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurosense Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Better Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Better Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Better Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Neurosense Therapeutics and Better Therapeutics

The main advantage of trading using opposite Neurosense Therapeutics and Better Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurosense Therapeutics position performs unexpectedly, Better Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Better Therapeutics will offset losses from the drop in Better Therapeutics' long position.

The idea behind Neurosense Therapeutics and Better Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.